• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
DU Hongjin,YU Xiaotan,LI Hanxu,WAN Luoting,ZOU Yu.Multi-step virtual screening for searching the 3Clpro inhibitor of the main protease of the new coronavirus SRAS-CoV-2[J].Journal Of Pharmaceutical Research,2023,42(10):801-806[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2491times   Download 2965次 QR Code for this article
Scan with your phone!
新冠病毒SARS-CoV-2主蛋白酶3CLpro抑制剂的多步虚拟筛选
杜宏金1,余晓谭2,3,李翰旭2,万洛婷2,邹瑜2
Font:Larger+|Default|Smaller-
(1.国家药品监督管理局药品审评中心,北京 100038;2.武汉科技大学医学院药学系,湖北省职业病预防与控制重点实验室,湖北 武汉 430070;3.华中科技大学同济医学院药学院,湖北 武汉 430030)
摘要:
目的 通过构建多步虚拟筛选模型和方法,寻找有效筛选新冠状病毒SARS-CoV-2主蛋白酶3CLpro抑制剂的方法,为抗击COVID-19提供去潜在的候选药物。方法 利用Discovery Studio Client 2016和AutoDock Vina 1.5.6软件对ZINC 数据库共5811个化合物进行基于结构的虚拟筛选,然后基于配体的药效团模型,选取最佳模型后进行基于配体的虚拟筛选,最后基于构效关系筛选出与抗病毒有关的药物。结果 经过3步筛选最终得到11个具有高亲和力、高拟合值和适当药理作用的化合物。结论 通过3种不同方法的多步筛选可以快速寻找出具有高活性的候选化合物,表明构建的虚拟筛选的方法和模型有效,为今后抗COVID-19药物研究提供了潜在的研究工具。
关键词:  COVID-19  SARS-CoV-2  虚拟筛选  药物再利用  分子对接
DOI:10.13506/j.cnki.jpr.2023.10.010
基金项目:国家自然科学基金资助项目(No.82003593);湖北省自然科学基金资助项目(No.2019CFB104)
Multi-step virtual screening for searching the 3Clpro inhibitor of the main protease of the new coronavirus SRAS-CoV-2
DU Hongjin1,YU Xiaotan2,3,LI Hanxu2,WAN Luoting2,ZOU Yu2
(1.Center for Drug Evaluation, National Medical Products Administration, Beijing 100038,China;2.Hubei Provincial Key Laboratory of Occupational Disease Prevention and Control, Department of Pharmacy, Wuhan University of Science and Technology, Wuhan 430065,China;3 School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030,China)
Abstract:
Objective To construct a multi-step virtual screening model and method to find an effective method for screening the 3Clpro inhibitor of the main protease of the new coronavirus SARS-CoV-2, so as to provide potential candidate drugs for COVID-19 drug research.Methods Discovery Studio Client 2016 and Autodock vina 1.5.6 software were used to conduct structural-based virtual screening of 5811 compounds from the ZINC database, and the ligand-based pharmacophore model was constructed. After selecting the best model, the ligand-based virtual screening was performed. Finally, the antiviral drugs were screened based on pharmacological effects.Results After three steps of screening, 11 compounds with high affinity, high fitting value and appropriate pharmacological effects were finally obtained.Conclusion After three different screening, the candidate compounds with high activity can be quickly found, indicating that the virtual screening method and model are effective, which will greatly reduce the range of drug screening against COVID-19 and provide potential research tools for future COVID-19 drug discovery.
Key words:  COVID-19  SARS-CoV-2  Virtual screening  Drug repurposing  Molecule docking
Today's Visits:485    Total Visits:2383197
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.